Healthequity (HQY) Stock
Health savings account administrator with investment services. Here's the price, business snapshot, and what's worth knowing about Healthequity in August 2026.
HealthEquity, Inc. (HQY) is a US-based administrator of health savings accounts (HSAs) and other consumer-directed health benefit solutions. Investors should know it combines account administration with investment services and technology for employers, insurers and individuals, generating revenue from per-account fees, asset management margins and transaction services. Growth drivers include rising HSA adoption, employer-sponsored benefit trends and expanding assets under administration, while profitability benefits from scale and recurring fee income. Key risks include regulatory changes to tax-advantaged accounts, competition from banks and fintechs, sensitivity to interest rates and investment market performance, and reliance on employer plan flows. With a market capitalisation around $8.3bn, HealthEquity is a mid-cap player exposed to both healthcare and financial-services dynamics. The stock may suit investors seeking exposure to long-term healthcare consumerisation, but performance can fluctuate; this summary is educational and not personalised investment advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying HealthEquity's stock with a target price of $121, indicating strong growth potential.
Financial Health
HealthEquity Inc is performing well with strong revenue, cash flow, and healthy profit margins.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
HSA Growth Tailwind
Rising HSA adoption and employer shifts towards consumer-directed benefits could expand account numbers and assets, though growth depends on regulation and employer decisions.
Platform Revenue Mix
Combination of recurring fees and asset-management spreads gives a diversified revenue base; scale can improve margins but results may vary with market conditions.
Regulation & Competition
Policy changes or new entrants from banks and fintechs could affect margins and growth, so investors should weigh regulatory risk alongside opportunity.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
